News
New DNA test spares thousands from unnecessary breast cancer chemo
A groundbreaking 2024 trial reveals a genetic screening tool that could spare up to 70,000 U.S. breast cancer patients annually from chemotherapy. The test identifies low-risk patients with near-total accuracy, transforming treatment protocols nationwide.